TMED4

gene
On this page

Also known as HNLFp24alpha3p24a3

Summary

TMED4 (transmembrane p24 trafficking protein 4, HGNC:22301) is a protein-coding gene on chromosome 7p13, encoding Transmembrane emp24 domain-containing protein 4 (Q7Z7H5). Involved in vesicular protein trafficking, mainly in the early secretory pathway. targeting.

Involved in positive regulation of canonical NF-kappaB signal transduction. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in several cellular components, including COPII-coated ER to Golgi transport vesicle; Golgi apparatus; and endoplasmic reticulum-Golgi intermediate compartment.

Source: NCBI Gene 222068 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 32 total
  • MANE Select transcript: NM_182547

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:22301
Approved symbolTMED4
Nametransmembrane p24 trafficking protein 4
Location7p13
Locus typegene with protein product
StatusApproved
AliasesHNLF, p24alpha3, p24a3
Ensembl geneENSG00000158604
Ensembl biotypeprotein_coding
OMIM612038
Entrez222068

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000289577, ENST00000444131, ENST00000457408, ENST00000477639, ENST00000481238, ENST00000947445

RefSeq mRNA: 6 — MANE Select: NM_182547 NM_001303058, NM_001303059, NM_001303060, NM_001303061, NM_001303062, NM_182547

CCDS: CCDS5493, CCDS78226, CCDS78227

Canonical transcript exons

ENST00000457408 — 5 exons

ExonStartEnd
ENSE000010398164458172344581823
ENSE000017950914458204744582231
ENSE000036769994458109344581239
ENSE000036837594458144944581574
ENSE000040348424457789444579628

Expression profiles

Bgee: expression breadth ubiquitous, 263 present calls, max score 99.51.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 56.4738 / max 371.8532, expressed in 1825 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
8388955.17181825
838900.6144361
838880.5163281
838870.171399

Top tissues by expression

263 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oviduct epitheliumUBERON:000480499.51gold quality
kidney epitheliumUBERON:000481998.80gold quality
corpus epididymisUBERON:000435998.53gold quality
caput epididymisUBERON:000435898.41gold quality
tracheaUBERON:000312698.03gold quality
superior surface of tongueUBERON:000737197.82gold quality
cauda epididymisUBERON:000436097.76gold quality
saphenous veinUBERON:000731897.67gold quality
ileal mucosaUBERON:000033197.41gold quality
duodenumUBERON:000211497.35gold quality
left lobe of thyroid glandUBERON:000112097.19gold quality
thyroid glandUBERON:000204697.15gold quality
renal medullaUBERON:000036297.02gold quality
right lobe of thyroid glandUBERON:000111996.90gold quality
fallopian tubeUBERON:000388996.85gold quality
tongueUBERON:000172396.74gold quality
cortex of kidneyUBERON:000122596.67gold quality
trigeminal ganglionUBERON:000167596.48gold quality
jejunal mucosaUBERON:000039996.41gold quality
adenohypophysisUBERON:000219696.38gold quality
pituitary glandUBERON:000000796.36gold quality
vena cavaUBERON:000408796.30gold quality
left ovaryUBERON:000211996.19gold quality
body of pancreasUBERON:000115096.15gold quality
pharyngeal mucosaUBERON:000035596.09gold quality
metanephros cortexUBERON:001053396.05gold quality
ovaryUBERON:000099296.01gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450295.98gold quality
adult mammalian kidneyUBERON:000008295.91gold quality
ponsUBERON:000098895.86gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-7303no2118.10
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

113 targeting TMED4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-4262100.0073.263931
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4533100.0069.482758
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-10401-5P99.9965.79948
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-450099.9972.722367
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-569699.9872.364487
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787
HSA-MIR-60799.9773.625593
HSA-MIR-314899.9775.066478
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562

Literature-anchored findings (GeneRIF, showing 1)

  • ERS25 may play a critical role in regulation of heat-shock response and apoptosis (PMID:18326488)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriotmed4ENSDARG00000024954
mus_musculusTmed4ENSMUSG00000004394
rattus_norvegicusTmed4ENSRNOG00000005016
drosophila_melanogasterp24-2FBGN0053105
drosophila_melanogasterecaFBGN0069242
caenorhabditis_elegansWBGENE00011606

Paralogs (8): TMED2 (ENSG00000086598), TMED1 (ENSG00000099203), TMED5 (ENSG00000117500), TMED7 (ENSG00000134970), TMED6 (ENSG00000157315), TMED3 (ENSG00000166557), TMED10 (ENSG00000170348), TMED9 (ENSG00000184840)

Protein

Protein identifiers

Transmembrane emp24 domain-containing protein 4Q7Z7H5 (reviewed: Q7Z7H5)

Alternative names: Endoplasmic reticulum stress-response protein 25, GMP25iso, Putative NF-kappa-B-activating protein 156, p24 family protein alpha-3

All UniProt accessions (2): Q7Z7H5, F8W7F7

UniProt curated annotations — full annotation on UniProt →

Function. Involved in vesicular protein trafficking, mainly in the early secretory pathway. targeting. Involved in the maintenance of the Golgi apparatus. Appears to play a role in the biosynthesis of secreted cargo including processing. Involved in endoplasmic reticulum stress response. May play a role in the regulation of heat-shock response and apoptosis.

Subcellular location. Endoplasmic reticulum membrane.

Similarity. Belongs to the EMP24/GP25L family.

Isoforms (3)

UniProt IDNamesCanonical?
Q7Z7H5-11yes
Q7Z7H5-22
Q7Z7H5-33

RefSeq proteins (6): NP_001289987, NP_001289988, NP_001289989, NP_001289990, NP_001289991, NP_872353* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR009038GOLD_domDomain
IPR015720Emp24-likeFamily

Pfam: PF01105

UniProt features (13 total): splice variant 3, topological domain 2, short sequence motif 2, signal peptide 1, chain 1, transmembrane region 1, domain 1, coiled-coil region 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7Z7H5-F186.020.51

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 117

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 155 (showing top): TGCGCANK_UNKNOWN, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, TGACCTY_ERR1_Q2, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, GOCC_COATED_VESICLE, HNF4_01, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GUO_HEX_TARGETS_DN, BASAKI_YBX1_TARGETS_DN, chr7p13, GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION

GO Biological Process (5): intracellular protein transport (GO:0006886), endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), Golgi organization (GO:0007030), positive regulation of canonical NF-kappaB signal transduction (GO:0043123), protein transport (GO:0015031)

GO Molecular Function (0):

GO Cellular Component (6): endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), Golgi apparatus (GO:0005794), COPII-coated ER to Golgi transport vesicle (GO:0030134), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoplasm4
intracellular membrane-bounded organelle3
intracellular protein localization2
intracellular transport2
endomembrane system2
protein transport1
intercellular transport1
Golgi vesicle transport1
organelle organization1
endomembrane system organization1
canonical NF-kappaB signal transduction1
regulation of canonical NF-kappaB signal transduction1
positive regulation of intracellular signal transduction1
transport1
establishment of protein localization1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
coated vesicle1
cellular anatomical structure1

Protein interactions and networks

STRING

874 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMED4TMED5Q9Y3A6689
TMED4TMED10P49755657
TMED4TMED1Q13445622
TMED4TM9SF3Q9HD45481
TMED4ACBD3Q9H3P7434
TMED4SSMEM1Q8WWF3421
TMED4TMED2Q15363420
TMED4EMC7Q9NPA0411
TMED4DYMQ7RTS9385
TMED4RNF212BA8MTL3371
TMED4UFC1Q9Y3C8358
TMED4IFT74Q96LB3358
TMED4TMED6Q8WW62356
TMED4MCFD2Q8NI22356
TMED4PITPNM1O00562353

IntAct

95 interactions, top by confidence:

ABTypeScore
GORASP2GOLGA2psi-mi:“MI:0914”(association)0.880
RFX3RFX1psi-mi:“MI:0914”(association)0.730
TMED10TMED1psi-mi:“MI:0914”(association)0.730
TMED9TMED10psi-mi:“MI:0914”(association)0.730
DDRGK1UFL1psi-mi:“MI:0914”(association)0.710
TMED2ATP9Apsi-mi:“MI:0914”(association)0.640
CHST8CANXpsi-mi:“MI:0914”(association)0.640
FBXO2TMEM131Lpsi-mi:“MI:0914”(association)0.530
FGF3GTPBP10psi-mi:“MI:0914”(association)0.530
IL13RA2METTL15psi-mi:“MI:0914”(association)0.530
NUP62RGPD8psi-mi:“MI:0914”(association)0.530
LIPGNRP1psi-mi:“MI:0914”(association)0.530
CDK5RAP3PLD2psi-mi:“MI:0914”(association)0.530
HEATR3SLC27A2psi-mi:“MI:0914”(association)0.530
SCN3BABCC5psi-mi:“MI:0914”(association)0.530
TMED3HS1BP3psi-mi:“MI:0914”(association)0.530
revTMED10psi-mi:“MI:0914”(association)0.460
Gorasp1CLIP-170psi-mi:“MI:0915”(physical association)0.400
Dennd6aIFT88psi-mi:“MI:0914”(association)0.350
Tmed10TARS3psi-mi:“MI:0914”(association)0.350
Tmed10NDUFS8psi-mi:“MI:0914”(association)0.350
Tmed2psi-mi:“MI:0914”(association)0.350
PDHA1psi-mi:“MI:0914”(association)0.350
ENGIGKV2-28psi-mi:“MI:0914”(association)0.350
PEBP1ANXA2P2psi-mi:“MI:0914”(association)0.350
Mpsi-mi:“MI:0914”(association)0.350
TMEM223psi-mi:“MI:0914”(association)0.350
MAPTSHTN1psi-mi:“MI:0914”(association)0.350

BioGRID (132): TMED4 (Affinity Capture-RNA), TMED4 (Affinity Capture-RNA), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Co-fractionation), TMED4 (Co-fractionation), TMED4 (Co-fractionation), TMED4 (Co-fractionation), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS)

ESM2 similar proteins: A0AQ71, B3LVB0, B3P6T8, B4GE47, B4HJV5, B4JYU5, B4K4G5, B4KB41, B4LYB8, B4MGF8, B4NIY1, B4NKL0, B4PUZ3, B4QWH9, F4J4Y0, O13770, O13946, O14324, O35587, O81045, P27869, P32803, P38819, P49755, P53198, Q05359, Q12403, Q12450, Q28735, Q3T133, Q4P958, Q54BN0, Q5E971, Q5I0E7, Q5RE32, Q63584, Q6C503, Q759T8, Q7Z7H5, Q8GYG1

Diamond homologs: A7SXK3, D3ZTX0, O17528, P32803, P49020, Q15363, Q3T133, Q54BN0, Q5I0E7, Q63524, Q6AY25, Q6BTC2, Q769F9, Q78IS1, Q7Z7H5, Q8R1V4, Q99KF1, Q9P7I9, Q9R0Q3, Q9Y3B3, Q9Y3Q3, B3MTS8, B3NZM5, B4GMC3, B4HJV5, B4JG34, B4KB41, B4LYB8, B4NKL0, B4PVC6, B4QWH9, O14324, O35587, P0CN72, P0CN73, P27869, P49755, P53198, Q28735, Q295B2

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 122 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
COPI-dependent Golgi-to-ER retrograde traffic79.7×2e-03
COPI-mediated anterograde transport79.6×2e-03

GO biological processes:

GO termPartnersFoldFDR
endoplasmic reticulum to Golgi vesicle-mediated transport1013.1×4e-06
Golgi organization911.6×3e-05
intracellular protein transport106.2×1e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

32 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance26
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

427 predictions. Top by Δscore:

VariantEffectΔscore
7:44579480:TA:Tdonor_gain1.0000
7:44579624:CGATA:Cacceptor_gain1.0000
7:44579627:TA:Tacceptor_gain1.0000
7:44579629:C:CCacceptor_gain1.0000
7:44581103:T:TAdonor_gain1.0000
7:44581235:ACCCG:Aacceptor_gain1.0000
7:44581236:CCCG:Cacceptor_gain1.0000
7:44581236:CCCGC:Cacceptor_gain1.0000
7:44581237:CCG:Cacceptor_gain1.0000
7:44581237:CCGC:Cacceptor_gain1.0000
7:44581238:CG:Cacceptor_gain1.0000
7:44581238:CGC:Cacceptor_gain1.0000
7:44581239:GC:Gacceptor_loss1.0000
7:44581240:C:CCacceptor_gain1.0000
7:44581443:TCTTA:Tdonor_loss1.0000
7:44581444:CTTA:Cdonor_loss1.0000
7:44581445:TTAC:Tdonor_loss1.0000
7:44581446:TAC:Tdonor_loss1.0000
7:44581447:A:ACdonor_gain1.0000
7:44581447:ACC:Adonor_loss1.0000
7:44581448:C:CAdonor_loss1.0000
7:44581448:C:CCdonor_gain1.0000
7:44581448:CCAG:Cdonor_gain1.0000
7:44581717:CCTTA:Cdonor_loss1.0000
7:44581718:CTTAC:Cdonor_loss1.0000
7:44581719:TTACC:Tdonor_loss1.0000
7:44581720:TA:Tdonor_loss1.0000
7:44581721:A:Tdonor_loss1.0000
7:44581722:C:CAdonor_loss1.0000
7:44581823:CCTG:Cacceptor_loss1.0000

AlphaMissense

1488 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:44579624:C:GR180P1.000
7:44579496:C:GA223P0.999
7:44579501:A:CF221C0.999
7:44579503:G:CF220L0.999
7:44579503:G:TF220L0.999
7:44579505:A:GF220L0.999
7:44579513:A:GL217P0.999
7:44579534:C:TG210D0.999
7:44579535:C:GG210R0.999
7:44579546:A:TL206H0.999
7:44579571:A:GW198R0.999
7:44579571:A:TW198R0.999
7:44579599:G:CS188R0.999
7:44579599:G:TS188R0.999
7:44579601:T:GS188R0.999
7:44579609:C:GR185P0.999
7:44579611:G:CF184L0.999
7:44579611:G:TF184L0.999
7:44579613:A:GF184L0.999
7:44581106:T:GQ174P0.999
7:44581145:C:GR161P0.999
7:44581154:A:GL158P0.999
7:44581196:T:CY144C0.999
7:44581229:A:GL133P0.999
7:44581498:C:GC113S0.999
7:44581498:C:TC113Y0.999
7:44581499:A:GC113R0.999
7:44581499:A:TC113S0.999
7:44581508:G:CH110D0.999
7:44581513:C:AG108V0.999

dbSNP variants (sampled 300 via entrez): RS1000017430 (7:44583714 A>G), RS1000063199 (7:44584130 C>T), RS1000161456 (7:44583226 T>C), RS1000359756 (7:44577813 A>G), RS1001407164 (7:44577424 C>A), RS1001671719 (7:44582704 G>C), RS1001703745 (7:44583087 C>T), RS1002023198 (7:44581571 C>A), RS1002977856 (7:44582166 C>G,T), RS1003684397 (7:44580083 G>T), RS1003736807 (7:44580396 T>G), RS1004138038 (7:44581894 G>T), RS1005808276 (7:44580242 G>A,C), RS1005866149 (7:44579979 A>G), RS1006497063 (7:44583395 C>G,T)

Disease associations

OMIM: gene MIM:612038 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

35 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aincreases expression2
entinostatdecreases expression, affects cotreatment2
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment, increases expression2
Hydrogen Peroxideaffects cotreatment, increases expression, affects expression2
Dronabinoldecreases expression, increases expression2
Valproic Acidincreases expression2
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression, increases expression2
methylmercuric chloridedecreases expression1
trichostatin Adecreases expression1
tetrahydropalmatinedecreases expression1
o,p’-DDTdecreases expression1
cupric oxidedecreases expression1
di-n-butylphosphoric acidaffects expression1
glycidamideincreases expression1
bisphenol Bincreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
bisphenol Sincreases expression1
LDN 193189affects cotreatment, increases expression1
NSC 689534affects binding, decreases expression1
bisphenol AFincreases expression1
Temozolomideincreases expression1
Acetaminophenincreases expression1
Copperaffects binding, decreases expression1
Diethylstilbestrolincreases expression1
Doxorubicindecreases expression1
Ivermectindecreases expression1
Methyl Methanesulfonateincreases expression1
Smokedecreases expression1
Theophyllineaffects cotreatment, increases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B3JEAbcam HEK293T TMED4 KOTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.